Working… Menu
Trial record 47 of 56 for:    insys

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00024661
Recruitment Status : Completed
First Posted : September 25, 2001
Last Update Posted : April 13, 2011
Georgetown University
Information provided by:
INSYS Therapeutics Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Primary Completion Date : No date given
Study Completion Date : October 2004